Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 273 |
| Last Trade Date Time: | 02/25/2026 09:30:20 am |
| Market Cap: | $263 |
|---|---|
| Float: | 2,583,736 |
| Insiders Ownership: | 3% |
| Institutions: | 3 |
| Short Percent: | 14999% |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.biocept.com |
| Country: | US |
| City: | San Diego |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Biocept Inc. (OTCMKTS: BIOCQ).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
